Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Ventavis Market Report 2016

  • QYR798770
  • 108 Pages
  • November 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Ventavis

Revenue, means the sales value of Ventavis

This report studies sales (consumption) of Ventavis in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Pfizer, Inc. (US)

Sanofi S.A (France)

Bayer HealthCare Pharmaceuticals (Germany)

Actelion Pharmaceuticals Ltd. (Switzerland)

Daiichi Sankyo Co., Ltd. (Japan)

Eli Lilly and Company (US)

YM BioSciences, Inc. (Canada)

GlaxoSmithKline Plc (UK)

Nippon Shinyaku Co., Ltd. (Japan)

Cipla Limited (India)

Arena Pharmaceuticals, Inc. (US)

The Novartis Group (Switzerland)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Ventavis in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

United States Ventavis Market Report 2016

1 Ventavis Overview

1.1 Product Overview and Scope of Ventavis

1.2 Classification of Ventavis

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Ventavis

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Ventavis (2011-2021)

1.4.1 United States Ventavis Sales and Growth Rate (2011-2021)

1.4.2 United States Ventavis Revenue and Growth Rate (2011-2021)

2 United States Ventavis Competition by Manufacturers

2.1 United States Ventavis Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Ventavis Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Ventavis Average Price by Manufactures (2015 and 2016)

2.4 Ventavis Market Competitive Situation and Trends

2.4.1 Ventavis Market Concentration Rate

2.4.2 Ventavis Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Ventavis Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Ventavis Sales and Market Share by Type (2011-2016)

3.2 United States Ventavis Revenue and Market Share by Type (2011-2016)

3.3 United States Ventavis Price by Type (2011-2016)

3.4 United States Ventavis Sales Growth Rate by Type (2011-2016)

4 United States Ventavis Sales (Volume) by Application (2011-2016)

4.1 United States Ventavis Sales and Market Share by Application (2011-2016)

4.2 United States Ventavis Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Ventavis Manufacturers Profiles/Analysis

5.1 Pfizer, Inc. (US)

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Ventavis Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 Pfizer, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Sanofi S.A (France)

5.2.2 Ventavis Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Sanofi S.A (France) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 Bayer HealthCare Pharmaceuticals (Germany)

5.3.2 Ventavis Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Actelion Pharmaceuticals Ltd. (Switzerland)

5.4.2 Ventavis Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 Daiichi Sankyo Co., Ltd. (Japan)

5.5.2 Ventavis Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Eli Lilly and Company (US)

5.6.2 Ventavis Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Eli Lilly and Company (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 YM BioSciences, Inc. (Canada)

5.7.2 Ventavis Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 YM BioSciences, Inc. (Canada) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 GlaxoSmithKline Plc (UK)

5.8.2 Ventavis Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 GlaxoSmithKline Plc (UK) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Nippon Shinyaku Co., Ltd. (Japan)

5.9.2 Ventavis Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Cipla Limited (India)

5.10.2 Ventavis Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Cipla Limited (India) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 Arena Pharmaceuticals, Inc. (US)

5.12 The Novartis Group (Switzerland)

6 Ventavis Manufacturing Cost Analysis

6.1 Ventavis Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Ventavis

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Ventavis Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Ventavis Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Ventavis Market Forecast (2016-2021)

10.1 United States Ventavis Sales, Revenue Forecast (2016-2021)

10.2 United States Ventavis Sales Forecast by Type (2016-2021)

10.3 United States Ventavis Sales Forecast by Application (2016-2021)

10.4 Ventavis Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

List of Tables and Figures

Figure Picture of Ventavis

Table Classification of Ventavis

Figure United States Sales Market Share of Ventavis by Type in 2015

Table Application of Ventavis

Figure United States Sales Market Share of Ventavis by Application in 2015

Figure United States Ventavis Sales and Growth Rate (2011-2021)

Figure United States Ventavis Revenue and Growth Rate (2011-2021)

Table United States Ventavis Sales of Key Manufacturers (2015 and 2016)

Table United States Ventavis Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Ventavis Sales Share by Manufacturers

Figure 2016 Ventavis Sales Share by Manufacturers

Table United States Ventavis Revenue by Manufacturers (2015 and 2016)

Table United States Ventavis Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Ventavis Revenue Share by Manufacturers

Table 2016 United States Ventavis Revenue Share by Manufacturers

Table United States Market Ventavis Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Ventavis Average Price of Key Manufacturers in 2015

Figure Ventavis Market Share of Top 3 Manufacturers

Figure Ventavis Market Share of Top 5 Manufacturers

Table United States Ventavis Sales by Type (2011-2016)

Table United States Ventavis Sales Share by Type (2011-2016)

Figure United States Ventavis Sales Market Share by Type in 2015

Table United States Ventavis Revenue and Market Share by Type (2011-2016)

Table United States Ventavis Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Ventavis by Type (2011-2016)

Table United States Ventavis Price by Type (2011-2016)

Figure United States Ventavis Sales Growth Rate by Type (2011-2016)

Table United States Ventavis Sales by Application (2011-2016)

Table United States Ventavis Sales Market Share by Application (2011-2016)

Figure United States Ventavis Sales Market Share by Application in 2015

Table United States Ventavis Sales Growth Rate by Application (2011-2016)

Figure United States Ventavis Sales Growth Rate by Application (2011-2016)

Table Pfizer, Inc. (US) Basic Information List

Table Pfizer, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer, Inc. (US) Ventavis Sales Market Share (2011-2016)

Table Sanofi S.A (France) Basic Information List

Table Sanofi S.A (France) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sanofi S.A (France) Ventavis Sales Market Share (2011-2016)

Table Bayer HealthCare Pharmaceuticals (Germany) Basic Information List

Table Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bayer HealthCare Pharmaceuticals (Germany) Ventavis Sales Market Share (2011-2016)

Table Actelion Pharmaceuticals Ltd. (Switzerland) Basic Information List

Table Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Actelion Pharmaceuticals Ltd. (Switzerland) Ventavis Sales Market Share (2011-2016)

Table Daiichi Sankyo Co., Ltd. (Japan) Basic Information List

Table Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Daiichi Sankyo Co., Ltd. (Japan) Ventavis Sales Market Share (2011-2016)

Table Eli Lilly and Company (US) Basic Information List

Table Eli Lilly and Company (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly and Company (US) Ventavis Sales Market Share (2011-2016)

Table YM BioSciences, Inc. (Canada) Basic Information List

Table YM BioSciences, Inc. (Canada) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table YM BioSciences, Inc. (Canada) Ventavis Sales Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table GlaxoSmithKline Plc (UK) Ventavis Sales Market Share (2011-2016)

Table Nippon Shinyaku Co., Ltd. (Japan) Basic Information List

Table Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Nippon Shinyaku Co., Ltd. (Japan) Ventavis Sales Market Share (2011-2016)

Table Cipla Limited (India) Basic Information List

Table Cipla Limited (India) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Cipla Limited (India) Ventavis Sales Market Share (2011-2016)

Table Arena Pharmaceuticals, Inc. (US) Basic Information List

Table Arena Pharmaceuticals, Inc. (US) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table Arena Pharmaceuticals, Inc. (US) Ventavis Sales Market Share (2011-2016)

Table The Novartis Group (Switzerland) Basic Information List

Table The Novartis Group (Switzerland) Ventavis Sales, Revenue, Price and Gross Margin (2011-2016)

Table The Novartis Group (Switzerland) Ventavis Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Ventavis

Figure Manufacturing Process Analysis of Ventavis

Figure Ventavis Industrial Chain Analysis

Table Raw Materials Sources of Ventavis Major Manufacturers in 2015

Table Major Buyers of Ventavis

Table Distributors/Traders List

Figure United States Ventavis Production and Growth Rate Forecast (2016-2021)

Figure United States Ventavis Revenue and Growth Rate Forecast (2016-2021)

Table United States Ventavis Production Forecast by Type (2016-2021)

Table United States Ventavis Consumption Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370